Cargando…

The clinical development of sGC modulators, riociguat and vericiguat

Detalles Bibliográficos
Autor principal:	Misselwitz, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565100/ http://dx.doi.org/10.1186/2050-6511-16-S1-A2

Ejemplares similares

The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT)
por: Huntgeburth, Michael, et al.
Publicado: (2015)

sGC redox regulation and asthma
por: Stuehr, Dennis J, et al.
Publicado: (2015)

Platelet inhibitory effects of the NO independent sGC stimulator riociguat (Bay 63-2561)
por: Reiss, Cora, et al.
Publicado: (2013)

Inhaled nitric oxide: an sGC-dependent IOP lowering agent
por: Lieb, Wolfgang S, et al.
Publicado: (2015)

Soluble guanylate cyclase (sGC) stimulator vericiguat alleviates myocardial ischemia-reperfusion injury by improving microcirculation
por: Cai, Yun, et al.
Publicado: (2022)

Effects of obesity on sGCβ(1) mediated signaling in white adipose tissue
por: Sanyal, Abhishek, et al.
Publicado: (2015)

A systems biology approach to cGMP suggests a prominent role for sGC in stroke: Validation by mechanism-based activation of apo-sGC in non-steal dosing coveys neuroprotection and increased survival
por: Casas, Ana I, et al.
Publicado: (2015)

The sGC stimulator BAY 41-8543 in a rat model of hypertension-induced heart failure
por: Haase, N, et al.
Publicado: (2015)

The cyclic nucleotide 3’,5’-cIMP produced by sGC is a second messenger in the vascular wall
por: Vanhoutte, Paul M, et al.
Publicado: (2015)

NMR study of a soluble Guanylate Cyclase (sGC) human homologue: the H-NOX domain from Nostoc sp.
por: Argyriou, Aikaterini, et al.
Publicado: (2015)

Concomitant administration of sGC stimulators with common classes of anti-hypertensive agents results in increased efficacy in spontaneously hypertensive rats
por: Germano, Peter, et al.
Publicado: (2015)

Age, noise and cGMP: Pharmacological activation of soluble guanylyl cyclase (sGC) interacts with the progression of age related and noise induced hearing loss
por: Rüttiger, Lukas, et al.
Publicado: (2015)

Structural insights into sGC
por: Akker, Focco van den, et al.
Publicado: (2009)

IWP-121: a novel sGC stimulator that reduces blood pressure and exhibits anti-fibrotic and anti-inflammatory activities in the Dahl Salt-Sensitive rat model
por: Shea, Courtney, et al.
Publicado: (2015)

New clinical results with sGC stimulators
por: Behr, Jürgen
Publicado: (2011)

Bioavailability, pharmacokinetics and safety of riociguat given as an oral suspension or crushed tablet with and without food
por: Saleh, Soundos, et al.
Publicado: (2015)

Riociguat and cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats
por: Reinke, Yvonne, et al.
Publicado: (2015)

Molecular aspects of sGC regulation
por: Marletta, Michael A, et al.
Publicado: (2011)

Targeting native and apo-sGC
por: Struthers, Mary, et al.
Publicado: (2013)

Lack of correlation between sGC subunit expression and sGC activity in cerebral development is due to non-heterodimerizing subunits in vivo
por: Haase, Nadine, et al.
Publicado: (2009)

Synthesis and evaluation of bifunctional sGC regulators
por: Chrominski, Mikolaj, et al.
Publicado: (2013)

Conformational changes involved in sGC activation
por: Marletta, Michael A, et al.
Publicado: (2013)

Riociguat for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): A subgroup analysis from the PATENT studies
por: Stephan, Rosenkranz, et al.
Publicado: (2015)

Is Innervation of the Neuromuscular Junction at the Diaphragm Modulated by sGC/cGMP Signaling?
por: Lukáčová, Nadežda, et al.
Publicado: (2020)

A Zebrafish Drug-Repurposing Screen Reveals sGC-Dependent and sGC-Independent Pro-Inflammatory Activities of Nitric Oxide
por: Wittmann, Christine, et al.
Publicado: (2015)

Synergistic mutations in soluble guanylyl cyclase (sGC) reveal a key role for interfacial regions in the sGC activation mechanism
por: Childers, Kenneth C., et al.
Publicado: (2019)

Functions of NO-GC1 and NO-GC2 in pain processing
por: Petersen, Jonas, et al.
Publicado: (2015)

A molecular view of the regulation of sGC activity
por: Marletta, Michael A, et al.
Publicado: (2009)

Structural insights into sGC activation by different activators
por: van den Akker, Focco, et al.
Publicado: (2011)

Genetic modifiers of hypertension in sGC-deficient mice
por: Buys, Emmanuel
Publicado: (2013)

ANMCO position paper on vericiguat use in heart failure: from evidence to place in therapy
por: Di Fusco, Stefania Angela, et al.
Publicado: (2023)

New vitamin B(12) derivatives activates sGC
por: Gryko, Dorota, et al.
Publicado: (2011)

Gemfibrozil as a potential heme-independent sGC activator
por: Sobolevsky, Michael, et al.
Publicado: (2011)

G-protein signaling modulator 1 is a modifier of sGC-dependent vascular response
por: Britton, George, et al.
Publicado: (2013)

Inhaled sGC Modulator Can Lower PH in Patients With COPD Without Deteriorating Oxygenation
por: Saffaran, Sina, et al.
Publicado: (2018)

NO-sGC Pathway Modulates Ca(2+) Release and Muscle Contraction in Zebrafish Skeletal Muscle
por: Xiyuan, Zhou, et al.
Publicado: (2017)

Are women at high risk for serous gynaecological cancer (SGC) opting for risk-reducing salphingo-oophorectomy motivated by high levels of anxiety and risk perceptions?
por: Meiser, B, et al.
Publicado: (2012)

Contribution of the NO-GC isoforms to airway responsiveness
por: Mergia, Evanthia, et al.
Publicado: (2015)

Differential role of NO-sensitive guanylyl cyclase isoforms NO-GC1 and NO-GC2 in auditory function in adult mice
por: Möhrle, Dorit, et al.
Publicado: (2015)

sGC activators and stimulators attenuate ischemia/reperfusion injury of the lung
por: Egemnazarov, Bakytbek, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_r38ie1m1c3jgun0d36qcnaalnh